Robert Eckert - 23 May 2025 Form 4 Insider Report for AMGEN INC (AMGN)

Role: Director
Signature: /s/ Robert A. Eckert
Issuer symbol: AMGN
Transactions as of: 23 May 2025
Net transactions value: $0
Form type: 4
Filing time: 28 May 2025, 20:59:47 UTC
Previous filing: 12 May 2025
Next filing: 12 Aug 2025
SEC: View on sec.gov

Quoteable Key Fact

"Robert Eckert filed Form 4 for AMGEN INC (AMGN) on 28 May 2025."

Quick Takeaways

This page summarizes Robert Eckert's Form 4 filing for AMGEN INC (AMGN).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 28 May 2025, 20:59.

What Changed

Previous filing in this sequence was filed on 12 May 2025.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
ECKERT ROBERT	Director	ONE AMGEN CENTER DRIVE, THOUSAND OAKS	/s/ Robert A. Eckert	23 May 2025	0001194256

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Award	$0	+809	+3.3%	$0.000000	25,027	23 May 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
F2	These shares include 3,384 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Content

The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

These shares include 3,384 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.